- Home
- MODD vs RANI Comparison
MODD vs RANI Comparison
Compare MODD & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODD
- RANI
- Stock Information
- Founded
- MODD 1998
- RANI 2012
- Country
- MODD United States
- RANI United States
- Employees
- MODD N/A
- RANI N/A
- Industry
- MODD Industrial Specialties
- RANI Medicinal Chemicals and Botanical Products
- Sector
- MODD Health Care
- RANI Health Care
- Exchange
- MODD Nasdaq
- RANI Nasdaq
- Market Cap
- MODD 46.8M
- RANI 55.3M
- IPO Year
- MODD N/A
- RANI 2021
- Fundamental
- Price
- MODD $1.08
- RANI $1.66
- Analyst Decision
- MODD Buy
- RANI Strong Buy
- Analyst Count
- MODD 1
- RANI 6
- Target Price
- MODD $5.00
- RANI $11.33
- AVG Volume (30 Days)
- MODD 69.5K
- RANI 2.3M
- Earning Date
- MODD 02-13-2025
- RANI 03-19-2025
- Dividend Yield
- MODD N/A
- RANI N/A
- EPS Growth
- MODD N/A
- RANI N/A
- EPS
- MODD N/A
- RANI N/A
- Revenue
- MODD N/A
- RANI N/A
- Revenue This Year
- MODD N/A
- RANI N/A
- Revenue Next Year
- MODD N/A
- RANI N/A
- P/E Ratio
- MODD N/A
- RANI N/A
- Revenue Growth
- MODD N/A
- RANI N/A
- 52 Week Low
- MODD $1.07
- RANI $1.24
- 52 Week High
- MODD $2.65
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- MODD 27.02
- RANI 54.80
- Support Level
- MODD $1.08
- RANI $1.59
- Resistance Level
- MODD $1.28
- RANI $1.90
- Average True Range (ATR)
- MODD 0.07
- RANI 0.15
- MACD
- MODD -0.00
- RANI 0.03
- Stochastic Oscillator
- MODD 4.46
- RANI 56.36
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.